Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04220892
Title Pilot Study of Pembrolizumab Combined With Pemetrexed or Abemaciclib for High Grade Glioma
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors Jose Carrillo
Indications

high grade glioma

Therapies

Abemaciclib + Pembrolizumab

Pembrolizumab + Pemetrexed Disodium

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.